The adderall shortage is because the DEA sets quotas on how much can be made per year. Despite increased prescriptions, the amounts produced have remained the same.[1][2]
The Wegovy shortage is because it was recently approved to treat obesity. The number of new prescriptions was larger than Novo Nordisk predicted, so they're still ramping up production.
The Wegovy shortage is because it was recently approved to treat obesity. The number of new prescriptions was larger than Novo Nordisk predicted, so they're still ramping up production.
1. https://www.federalregister.gov/documents/2021/12/02/2021-26...
2. https://www.federalregister.gov/documents/2022/12/02/2022-26...